Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease | Cardiovascular Diabetology

by

  • Van der Schueren B, Ellis D, Faradji RN, Al-Ozairi E, Rosen J, Mathieu C. Obesity in people living with type 1 diabetes. Lancet Diabetes Endocrinol. 2021;9(11):776–85.

    PubMed 

    Google Scholar     

  • Bielka W, Przezak A, Molęda P, Pius-Sadowska E, Machaliński B. Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol. 2024;23(1):62.

    PubMed 
    PubMed Central 

    Google Scholar     

  • Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:93.


    Google Scholar     

  • EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic…

    • Source link

    Related posts:

    1. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity | Cardiovascular Diabetology
    2. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes | Cardiovascular Diabetology
    3. Association of insulin resistance surrogates with disease severity and adverse outcomes in chronic thromboembolic pulmonary hypertension: a multicenter cohort study | Cardiovascular Diabetology
    4. Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction | Cardiovascular Diabetology

    Leave a Comment